Table 3. Adverse events occurring at any grade in the study subjects (n = 50).
All grades, no. (%) | Grade ≥ 3, no. (%) | |
---|---|---|
Hematologic | ||
Leukopenia | 46 (92) | 23 (46) |
Neutropenia | 39 (78) | 23 (46) |
Anemia | 50 (100) | 3 (6) |
Thrombocytopenia | 33 (66) | 2 (4) |
Febrile neutropenia | 5 (10) | 5 (10) |
Nonhematologic | ||
Anorexia | 26 (52) | 2 (4) |
Constipation | 33 (66) | 0 (0) |
Mucosal inflammation | 21 (42) | 0 (0) |
Esophagitis | 31 (62) | 0 (0) |
Fatigue | 24 (48) | 2 (4) |
Nausea | 27 (54) | 2 (4) |
Vomiting | 9 (18) | 0 (0) |
Diarrhea | 5 (10) | 0 (0) |
Pyrexia | 14 (28) | 0 (0) |
Elevated AST | 12 (24) | 0 (0) |
Elevated ALT | 18 (36) | 0 (0) |
Increased total bilirubin | 9 (18) | 0 (0) |
Increased creatinine | 17 (34) | 2 (4) |
Hyperkalemia | 29 (58) | 1 (2) |
Hyponatremia | 31 (62) | 8 (16) |
Pneumonitis | 8 (16) | 1 (2) |
Esophageal perforation | 3 (6) | 3 (6) |
Pericardial effusion | 6 (12) | 0 (0) |
Abbreviations: AST, aspartate aminotransferase; ALT, alanine aminotransferase.